IP Verse

Use Of Cladribine For Treating Neuromyelitis Optica - EP3099307

EP3099307

CHORD THERAPEUTICS
Application Number
EP15702549A
Filing Date
Jan 27, 2015
Status
Patent Maintained As Amended
Jun 26, 2020
Grant Date
Jul 29, 2020
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3099307B2 was granted to Chord Therapeutics on Jul 29, 2020 following the initial filing on Jan 27, 2015 under the application number EP15702549A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK PATENTJul 18, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents